Potent, competitive, transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor. Also available as part of the Excitatory Amino Acid Transporter Inhibitor Tocriset™.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 100 mM in 1eq. NaOH|
Preparing Stock Solutions
The following data is based on the product molecular weight 149.1. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||6.71 mL||33.53 mL||67.07 mL|
|5 mM||1.34 mL||6.71 mL||13.41 mL|
|10 mM||0.67 mL||3.35 mL||6.71 mL|
|50 mM||0.13 mL||0.67 mL||1.34 mL|
References are publications that support the products' biological activity.
Johnston et al (1980) Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3-hydroxyaspartate. J.Neurochem. 34 241 PMID: 7452241
McBean and Roberts (1985) Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J.Neurochem. 44 247 PMID: 2856883
Nakamura et al (1993) (2S,3S,4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology 32 833 PMID: 7901789
If you know of a relevant reference for L-(-)-threo-3-Hydroxyaspartic acid, please let us know.
View Related Products by Product Action
Keywords: L-(-)-threo-3-Hydroxyaspartic acid, supplier, potent, competitive, Transportable, EAAT1, EAAT2, EAAT3, EAAT4, EAAT1-4, inhibitors, inhibits, non-transportable, EAAT5, Excitatory, Amino, Acid, Transporters, GLAST, GLT-1, Glutamate, Monoamine, Neurotransmitter, reuptake, L-threo-beta-Hydroxyaspartic, acid, L-threo-b-Hydroxyaspartic, acid, Glutamate, Transporters, Glutamate, Transporters, Tocris Bioscience
Citations for L-(-)-threo-3-Hydroxyaspartic acid
Citations are publications that use Tocris products.
Currently there are no citations for L-(-)-threo-3-Hydroxyaspartic acid. Do you know of a great paper that uses L-(-)-threo-3-Hydroxyaspartic acid from Tocris? If so please let us know.
L-(-)-threo-3-Hydroxyaspartic acid Reviews
Average Rating:(Based on 0 Reviews)
Literature in this Area
Huntington's Disease Poster
Huntington's disease (HD) is a monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the MSN intracellular signaling pathways implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.